Sexual Dysfunction in Male Patients Linked to ADHD Medication

According to an edition of Drug Safety that was published in August of 2013, Strattera (atomoxetine), an attention-deficit hyperactivity disorder (ADHD) medication, is known to cause side effects that include sexual dysfunction in male patients. The medication, which is a norepinephrine reuptake inhibitor (NRI), has been approved by the United States Food and Drug Administration (FDA) and is generally assumed to be a safe alternative to other stimulant treatments for ADHD such as Adderall. Without the same potential for abuse among users as Adderall, Stattera has become a popular option; however, new findings could alter the drug’s current popularity.

Stattera has been on the market since November of 2002, and only now are the sexual dysfunction side effects of the drug being recognized. Researchers studying the drug have found that the rates of adverse sexual side effects from the drug are highest among adult males taking Strattera. Females and adolescent males taking the ADHD medication showed far less impact in this area.

The investigative study concluded that sexual and GU TEAEs (genitourinary treatment-emergent events) are more prevalent in adult males taking Strattera than any other group; however, we must keep in mind that results could be skewed because of possible underreporting. Additional side effects felt by the drug include:

  • Somnolence
  • Fatigue
  • Drug ineffectiveness

If you or someone you love suffered from the use of Stattera, don’t hesitate to contact a defective drug lawyer at The Senators Firm. By calling us toll-free at (949) 557-5800, you can speak to a professional about scheduling a free consultation with an attorney at our office. Together, we can determine the best course of action to take regarding your situation and then move forward accordingly.